Dabigatran for the Treatment and Secondary Prevention of Venous Thromboembolism; A Cost-Effectiveness Analysis for the Netherlands

BACKGROUND: Dabigatran was proven to have similar effect on the prevention of recurrence of venous thromboembolism (VTE) and a lower risk of bleeding compared to vitamin K antagonists (VKA). The aim of this study is to assess the cost-effectiveness (CE) of dabigatran for the treatment and secondary...

Descripción completa

Detalles Bibliográficos
Autores principales: Stevanović, J., de Jong, L. A., Kappelhoff, B. S., Dvortsin, E. P., Voorhaar, M., Postma, M. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077099/
https://www.ncbi.nlm.nih.gov/pubmed/27776137
http://dx.doi.org/10.1371/journal.pone.0163550

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5077099/
https://www.ncbi.nlm.nih.gov/pubmed/27776137
http://dx.doi.org/10.1371/journal.pone.0163550

Ejemplares similares